CHEBI:18056 - N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide
ChEBI ID CHEBI:18056
ChEBI ASCII Name N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide
Definition A glycopentaosylceramide having α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc as the pentasaccharide portion; reported to be the Forssman hapten of horse spleen.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:12561, CHEBI:7119, CHEBI:21514
Download Molfile XML SDF
Formula C53H92N3O28R
Net Charge 0
Average Mass (excl. R groups) 1219.303
Monoisotopic Mass (excl. R groups) 1218.58673
SMILES [C@@H]1([C@H](O[C@@H](O[C@@H]2[C@H]([C@H](O[C@H]3[C@H](O[C@@H](O[C@@H]4[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]4O)O)CO)[C@@H]([C@H]3O)O)CO)O[C@@H]([C@@H]2O)CO)O)[C@@H]([C@H]1O[C@H]5[C@@H]([C@H]([C@@H](O)[C@H](O5)CO)O)NC(C)=O)NC(C)=O)CO)O
Metabolite of Species Details
Mus musculus (NCBI:txid10090) Source: BioModels - MODEL1507180067 See: PubMed
Roles Classification
Biological Role(s): mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide )
View more via ChEBI Ontology
ChEBI Ontology
Outgoing N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18056) has role mouse metabolite (CHEBI:75771)
N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18056) is a α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-Cer (CHEBI:90400)
N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18056) is a glycopentaosylceramide (CHEBI:23073)
Incoming α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-(β-D-Gal-(1→3)-β-D-GalNAc-(1→4))-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-ceramide(d18:1(4E)) (CHEBI:141190) has functional parent N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramide (CHEBI:18056)
IUPAC Name
N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-α-D-galactopyranosyl-(1→3)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→3)-α-D-galactopyranosyl-(1→4)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
Synonyms Sources
(Gal)2 (GalNAc)2 (Glc)1 (Cer)1 KEGG GLYCAN
α-D-GalNAc-(1→3)-β-D-GalNAc-(1→3)-α-D-Gal-(1→4)-β-D-Gal-(1→4)-β-D-Glc(1↔1)Cer ChEBI
Forssman hapten KEGG COMPOUND
GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->4Gal-beta1->4Glc-beta1->1'Cer KEGG COMPOUND
GalNAc-alpha1->3GalNAc-beta1->3Gal-alpha1->4LacCer KEGG COMPOUND
globoside Forssman (d18:1(4E)) UniProt
IV3GalNAcα-Gb4Cer ChEBI
N-acetyl-α-D-galactosaminyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosylceramides ChEBI
N-Acetyl-D-galactosaminyl-N-Acetyl-D-galactosaminyl-1,3-D-galactosyl-1,4-D-galactosyl-1,4-D-glucosylceramide KEGG COMPOUND
Manual Xrefs Databases
C04925 KEGG COMPOUND
G00095 KEGG GLYCAN
View more database links
Citations Waiting for Citations Types Sources
10988247 PubMed citation Europe PMC
1193672 PubMed citation Europe PMC
13239189 PubMed citation Europe PMC
13239190 PubMed citation Europe PMC
1373469 PubMed citation Europe PMC
14210803 PubMed citation Europe PMC
1528196 PubMed citation Europe PMC
19351707 PubMed citation Europe PMC
4199759 PubMed citation Europe PMC
4358346 PubMed citation Europe PMC
4459265 PubMed citation Europe PMC
4474139 PubMed citation Europe PMC
4538505 PubMed citation Europe PMC
4605408 PubMed citation Europe PMC
469271 PubMed citation Europe PMC
5461254 PubMed citation Europe PMC
8623166 PubMed citation Europe PMC
Last Modified
07 June 2022